Changde Yungang Bio Makes Its Debut at API China Chongqing 2025, Spotlighting Bile-Derived Products and Industry Trends
From November 12 to 14, 2025, Changde Yungang Bio will make its debut at the API China Chongqing exhibition, showcasing a comprehensive portfolio of bile-related products, including bilirubin, chenodeoxycholic acid, ursodeoxycholic acid, bile salts, and bile acid feed additives. During the event, the company engaged in in-depth exchanges with industry peers on technological trends and market demands, expanded its network of collaborative partners, and received an enthusiastic response from attendees. Looking ahead, Yungang Bio will continue to deepen its expertise in the bile resource sector, delivering higher-quality products and services to customers and working together to create new value for the industry.